Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isotonic sea water is a nasal hygiene solution developed by SAVA Healthcare, formulated to match the osmotic pressure of human body fluids. It is primarily used as a nasal spray to facilitate the mechanical clearance of thickened mucus, allergens, pollutants, and pathogens from the nasal cavity. By providing hydration to the nasal mucosa and thinning secretions, it helps alleviate symptoms of nasal congestion associated with conditions such as the common cold, sinusitis, and allergic rhinitis. As a non-pharmacological product, it contains essential minerals and trace elements found in sea water and is suitable for long-term use in both adults and children to maintain respiratory hygiene and relieve dryness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isotonic sea water.